Market Cap ₹2780 Cr.
Stock P/E 20.6
P/B 2
Current Price ₹1863
Book Value ₹ 918
Face Value 10
52W High ₹2800
Dividend Yield 1.07%
52W Low ₹ 1700
Nilkamal Ltd is an primarily India based producer of molded furniture and processor of plastic molded products. The Company operates through 2 segments: Plastics and Lifestyle Furniture, Furnishings and Accessories. The Company's commercial enterprise consists of material handling solutions, ready furniture, @Home - the brand name, lifestyle home solutions retail chain, Nilkamal Mattrezzz, and BubbleGUARD - a material protection solution. Its furniture enterprise includes domestic furniture, workplace furniture and mattresses. Its Nilkamal Mattrezzz includes Spring Mattrezzz, Foam Mattrezzz, Coir Mattrezzz, and Orthopaedic Mattrezzz. @Home is a retail division of the Company, which offers furniture, homeware and add-ons. Nilkamal BubbleGUARD is a multi-layer polypropylene board with a circular honeycomb-established core. Its board provides safety, packaging, printing and paneling solutions to industries, along with creation, automotive, steelworks, furnishings, marketing, decor and logistics.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 739 | 756 | 742 | 740 | 808 | 754 | 829 | 783 | 776 | 803 |
Other Income | 1 | 0 | 9 | 3 | 2 | 3 | 4 | 3 | 6 | 2 |
Total Income | 740 | 757 | 751 | 742 | 810 | 757 | 832 | 786 | 782 | 806 |
Total Expenditure | 672 | 682 | 692 | 671 | 742 | 678 | 732 | 709 | 714 | 731 |
Operating Profit | 68 | 74 | 59 | 71 | 68 | 79 | 101 | 77 | 68 | 75 |
Interest | 7 | 7 | 8 | 8 | 9 | 9 | 10 | 9 | 9 | 10 |
Depreciation | 25 | 25 | 27 | 27 | 28 | 29 | 29 | 28 | 29 | 29 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 37 | 41 | 25 | 35 | 30 | 41 | 62 | 40 | 30 | 36 |
Provision for Tax | 9 | 10 | 6 | 9 | 8 | 10 | 16 | 10 | 7 | 9 |
Profit After Tax | 27 | 31 | 18 | 27 | 22 | 31 | 46 | 30 | 23 | 27 |
Adjustments | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 |
Profit After Adjustments | 28 | 33 | 20 | 29 | 24 | 33 | 48 | 32 | 25 | 29 |
Adjusted Earnings Per Share | 18.9 | 22.4 | 13.4 | 19.2 | 16 | 22.2 | 32.3 | 21.7 | 16.8 | 19.6 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 1702 | 1742 | 1895 | 1926 | 2024 | 2124 | 2362 | 2257 | 2092 | 2730 | 3131 | 3191 |
Other Income | 4 | 4 | 5 | 3 | 3 | 4 | 13 | 14 | 16 | 12 | 11 | 15 |
Total Income | 1706 | 1745 | 1899 | 1930 | 2027 | 2128 | 2375 | 2272 | 2108 | 2742 | 3142 | 3206 |
Total Expenditure | 1566 | 1585 | 1738 | 1694 | 1790 | 1882 | 2146 | 1973 | 1836 | 2506 | 2819 | 2886 |
Operating Profit | 140 | 161 | 161 | 236 | 238 | 246 | 229 | 298 | 272 | 236 | 323 | 321 |
Interest | 45 | 43 | 33 | 21 | 14 | 16 | 18 | 29 | 26 | 31 | 40 | 38 |
Depreciation | 48 | 52 | 57 | 55 | 51 | 50 | 52 | 94 | 97 | 101 | 113 | 115 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 48 | 66 | 71 | 168 | 178 | 187 | 166 | 182 | 150 | 109 | 177 | 168 |
Provision for Tax | 10 | 18 | 20 | 52 | 54 | 63 | 48 | 39 | 37 | 26 | 43 | 42 |
Profit After Tax | 38 | 48 | 51 | 116 | 124 | 124 | 118 | 142 | 113 | 83 | 134 | 126 |
Adjustments | -1 | -1 | -1 | -2 | -2 | -0 | -0 | -0 | -0 | -0 | -0 | 9 |
Profit After Adjustments | 37 | 47 | 50 | 114 | 123 | 123 | 117 | 142 | 113 | 83 | 134 | 134 |
Adjusted Earnings Per Share | 24.9 | 31.5 | 33.8 | 76.4 | 82.1 | 82.7 | 78.6 | 95.2 | 75.7 | 55.9 | 89.8 | 90.4 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 15% | 12% | 8% | 6% |
Operating Profit CAGR | 37% | 3% | 6% | 9% |
PAT CAGR | 61% | -2% | 2% | 13% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -10% | -4% | 8% | 24% |
ROE Average | 11% | 9% | 11% | 13% |
ROCE Average | 15% | 14% | 16% | 17% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 445 | 487 | 525 | 628 | 742 | 849 | 941 | 1032 | 1139 | 1202 | 1314 |
Minority's Interest | 5 | 5 | 6 | 7 | 7 | 7 | 7 | 1 | 1 | 1 | 1 |
Borrowings | 113 | 93 | 44 | 9 | 0 | 0 | 44 | 48 | 29 | 117 | 160 |
Other Non-Current Liabilities | 63 | 66 | 62 | 57 | 63 | 74 | 85 | 204 | 238 | 232 | 229 |
Total Current Liabilities | 447 | 390 | 332 | 297 | 281 | 319 | 216 | 266 | 317 | 402 | 371 |
Total Liabilities | 1073 | 1041 | 969 | 998 | 1093 | 1248 | 1294 | 1551 | 1724 | 1953 | 2075 |
Fixed Assets | 365 | 357 | 306 | 273 | 271 | 344 | 399 | 592 | 634 | 695 | 782 |
Other Non-Current Assets | 57 | 61 | 55 | 90 | 120 | 101 | 116 | 99 | 91 | 113 | 105 |
Total Current Assets | 651 | 623 | 608 | 635 | 702 | 803 | 779 | 860 | 999 | 1145 | 1188 |
Total Assets | 1073 | 1041 | 969 | 998 | 1093 | 1248 | 1294 | 1551 | 1724 | 1953 | 2075 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 14 | 11 | 16 | 14 | 13 | 13 | 17 | 13 | 18 | 31 | 65 |
Cash Flow from Operating Activities | 74 | 173 | 167 | 183 | 112 | 121 | 175 | 252 | 203 | 69 | 190 |
Cash Flow from Investing Activities | -57 | -39 | -15 | -41 | -70 | -96 | -106 | -152 | -121 | -89 | -165 |
Cash Flow from Financing Activities | -19 | -131 | -151 | -142 | -38 | -20 | -73 | -100 | -71 | 60 | -71 |
Net Cash Inflow / Outflow | -2 | 3 | 1 | -1 | 3 | 5 | -4 | -0 | 11 | 40 | -46 |
Closing Cash & Cash Equivalent | 11 | 16 | 17 | 13 | 13 | 17 | 13 | 18 | 31 | 65 | 20 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 24.89 | 31.53 | 33.83 | 76.44 | 82.11 | 82.74 | 78.63 | 95.21 | 75.68 | 55.86 | 89.76 |
CEPS(Rs) | 57.26 | 66.88 | 72.83 | 114.58 | 117.2 | 116.83 | 113.49 | 158.58 | 140.94 | 123.6 | 165.78 |
DPS(Rs) | 4 | 4 | 4.5 | 7 | 11 | 13 | 13 | 15 | 15 | 15 | 20 |
Book NAV/Share(Rs) | 298.13 | 326.19 | 351.8 | 420.52 | 497.19 | 568.66 | 630.71 | 691.63 | 763.53 | 805.17 | 880.69 |
Core EBITDA Margin(%) | 7.03 | 8.52 | 7.72 | 11.29 | 10.84 | 11.21 | 9.14 | 12.58 | 12.23 | 8.2 | 9.95 |
EBIT Margin(%) | 4.77 | 5.88 | 5.11 | 9.14 | 8.9 | 9.36 | 7.8 | 9.32 | 8.43 | 5.14 | 6.93 |
Pre Tax Margin(%) | 2.45 | 3.57 | 3.5 | 8.13 | 8.23 | 8.65 | 7.02 | 8.04 | 7.18 | 4.01 | 5.65 |
PAT Margin (%) | 1.95 | 2.58 | 2.53 | 5.63 | 5.75 | 5.73 | 4.98 | 6.31 | 5.41 | 3.06 | 4.28 |
Cash Profit Margin (%) | 4.4 | 5.41 | 5.37 | 8.3 | 8.09 | 8.07 | 7.17 | 10.48 | 10.05 | 6.76 | 7.9 |
ROA(%) | 3.68 | 4.5 | 5.1 | 11.79 | 11.89 | 10.58 | 9.26 | 10.01 | 6.91 | 4.54 | 6.65 |
ROE(%) | 8.82 | 10.21 | 10.13 | 20.12 | 18.16 | 15.57 | 13.15 | 14.44 | 10.42 | 7.13 | 10.65 |
ROCE(%) | 11.32 | 13.03 | 13.38 | 25.68 | 24.7 | 22.91 | 18.98 | 20.05 | 15.42 | 10.95 | 15.07 |
Receivable days | 43.12 | 47.75 | 43.55 | 45.74 | 48.12 | 54.14 | 50.15 | 51.26 | 55.22 | 41.58 | 43.56 |
Inventory Days | 57.86 | 63.56 | 54.85 | 52.89 | 54.08 | 60.42 | 59.66 | 64.62 | 78.88 | 77.49 | 76.79 |
Payable days | 32.81 | 33.71 | 30.23 | 34.24 | 35.01 | 43.19 | 39.97 | 41.97 | 53.58 | 45.43 | 43.24 |
PER(x) | 6.89 | 6.26 | 12.48 | 14.46 | 23.77 | 18.39 | 18.21 | 10.54 | 25.77 | 36.36 | 19.52 |
Price/Book(x) | 0.58 | 0.6 | 1.2 | 2.63 | 3.93 | 2.68 | 2.27 | 1.45 | 2.55 | 2.52 | 1.99 |
Dividend Yield(%) | 2.33 | 2.03 | 1.07 | 0.63 | 0.56 | 0.85 | 0.91 | 1.5 | 0.77 | 0.74 | 1.14 |
EV/Net Sales(x) | 0.37 | 0.34 | 0.43 | 0.9 | 1.47 | 1.1 | 0.92 | 0.68 | 1.37 | 1.15 | 0.89 |
EV/Core EBITDA(x) | 4.54 | 3.69 | 5.09 | 7.37 | 12.54 | 9.52 | 9.52 | 5.16 | 10.55 | 13.31 | 8.62 |
Net Sales Growth(%) | 12.24 | 2.33 | 8.77 | 1.68 | 5.06 | 4.94 | 11.22 | -4.45 | -7.31 | 30.49 | 14.68 |
EBIT Growth(%) | -22.38 | 17.08 | -4.67 | 82.21 | 2.15 | 8.13 | -8.93 | 14.18 | -13.62 | -19.66 | 54.55 |
PAT Growth(%) | -38.82 | 25.65 | 7.75 | 126.23 | 7.23 | 3.95 | -4.98 | 21.01 | -16.89 | -25.18 | 60.63 |
EPS Growth(%) | -39.22 | 26.67 | 7.29 | 125.97 | 7.42 | 0.76 | -4.97 | 21.09 | -20.52 | -26.2 | 60.71 |
Debt/Equity(x) | 0.92 | 0.67 | 0.4 | 0.17 | 0.11 | 0.11 | 0.06 | 0.06 | 0.04 | 0.15 | 0.14 |
Current Ratio(x) | 1.46 | 1.6 | 1.83 | 2.14 | 2.5 | 2.52 | 3.61 | 3.23 | 3.15 | 2.85 | 3.2 |
Quick Ratio(x) | 0.73 | 0.79 | 0.95 | 1.11 | 1.3 | 1.33 | 1.79 | 1.7 | 1.58 | 1.2 | 1.43 |
Interest Cover(x) | 2.06 | 2.55 | 3.18 | 9.07 | 13.38 | 13.01 | 10.05 | 7.3 | 6.73 | 4.55 | 5.44 |
Total Debt/Mcap(x) | 1.59 | 1.1 | 0.33 | 0.06 | 0.03 | 0.04 | 0.03 | 0.04 | 0.02 | 0.06 | 0.07 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 64.53 | 64.53 | 64.53 | 64.54 | 64.54 | 64.54 | 64.54 | 64.54 | 64.54 | 64.54 |
FII | 2.2 | 2.13 | 1.93 | 1.87 | 1.44 | 1.1 | 1.02 | 1.16 | 1.16 | 1.14 |
DII | 19.45 | 19.58 | 19.82 | 19.72 | 19.86 | 19.8 | 19.84 | 20.22 | 20 | 19.12 |
Public | 13.82 | 13.76 | 13.72 | 13.88 | 14.16 | 14.56 | 14.49 | 14.08 | 14.3 | 15.2 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0.11 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 |
FII | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
DII | 0.29 | 0.29 | 0.3 | 0.29 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.29 |
Public | 0.21 | 0.21 | 0.2 | 0.21 | 0.21 | 0.22 | 0.22 | 0.21 | 0.21 | 0.23 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1.49 | 1.49 | 1.49 | 1.49 | 1.49 | 1.49 | 1.49 | 1.49 | 1.49 | 1.49 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About